Instructions for Preparing and giving Chemotherapy by Mouth
https://libcat.nshealth.ca/en/permalink/chpams37983
IWK. Hematology / Oncology, IWK. Nephrology.
Halifax, NS:
IWK Health Centre
, 2022.
- Pamphlet Number
- PL-1104
- Available Online
- View Pamphlet
Chemotherapy is a group of medicines that treat cancer. They may destroy cancer cells or stop them from growing. Although the risk of danger from handling chemotherapy is small, it is a good idea to avoid exposure. This information sheet will help you to safely prepare, give, store and dispose of your child's oral chemotherapy drug.
- Available Online
- View Pamphlet
- Corporate Author
- IWK. Hematology / Oncology
- IWK. Nephrology
- Alternate Title
- If you need to crush a chemotherapy tablet
- Place of Publication
- Halifax, NS
- Publisher
- IWK Health Centre
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document : digital, PDF file
- Subjects (MeSH)
- Administration, Oral
- Antineoplastic Agents
- Neoplasms - drug therapy
- Pharmaceutical Preparations
- Subjects (LCSH)
- Cancer--Chemotherapy
- Abstract
- Chemotherapy is a group of medicines that treat cancer. They may destroy cancer cells or stop them from growing. Although the risk of danger from handling chemotherapy is small, it is a good idea to avoid exposure. This information sheet will help you to safely prepare, give, store and dispose of your child's oral chemotherapy drug.
- Responsibility
- IWK Hematology / Oncology, Halifax, NS
- Pamphlet Number
- PL-1104
Instructions for Preparing and giving Chemotherapy by Mouth
https://libcat.nshealth.ca/en/permalink/chpams37985
IWK. Hematology / Oncology, IWK. Nephrology.
Halifax, NS:
IWK Health Centre
, 2022.
- Pamphlet Number
- PL-1106
- Available Online
- View Pamphlet
Depending on the complexity of your child’s care, tests and clinic visits may be scheduled over 2 or more days. This may not include test/scan results. The staff at the IWK work hard to schedule and accommodate your child’s needs as best as possible in order to limit the amount of time you spend at the health centre.
- Available Online
- View Pamphlet
- Corporate Author
- IWK. Hematology / Oncology
- IWK. Nephrology
- Alternate Title
- if your dose, or your child’s dose, is in Liquid Form
- Place of Publication
- Halifax, NS
- Publisher
- IWK Health Centre
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document : digital, PDF file
- Subjects (MeSH)
- Administration, Oral
- Antineoplastic Agents
- Neoplasms - drug therapy
- Pharmaceutical Preparations
- Subjects (LCSH)
- Cancer--Chemotherapy
- Abstract
- Depending on the complexity of your child’s care, tests and clinic visits may be scheduled over 2 or more days. This may not include test/scan results. The staff at the IWK work hard to schedule and accommodate your child’s needs as best as possible in order to limit the amount of time you spend at the health centre.
- Responsibility
- IWK Hematology / Oncology, Halifax, NS
- Pamphlet Number
- PL-1106
Instructions for Preparing and giving Chemotherapy by Mouth
https://libcat.nshealth.ca/en/permalink/chpams37986
IWK. Hematology / Oncology, IWK. Nephrology.
Halifax, NS:
IWK Health Centre
, 2022.
- Pamphlet Number
- PL-1107
- Available Online
- View Pamphlet
Depending on the complexity of your child’s care, tests and clinic visits may be scheduled over 2 or more days. This may not include test/scan results. The staff at the IWK work hard to schedule and accommodate your child’s needs as best as possible in order to limit the amount of time you spend at the health centre.
- Available Online
- View Pamphlet
- Corporate Author
- IWK. Hematology / Oncology
- IWK. Nephrology
- Alternate Title
- Opening Capsules
- Place of Publication
- Halifax, NS
- Publisher
- IWK Health Centre
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document : digital, PDF file
- Subjects (MeSH)
- Administration, Oral
- Antineoplastic Agents
- Neoplasms - drug therapy
- Pharmaceutical Preparations
- Subjects (LCSH)
- Cancer--Chemotherapy
- Abstract
- Depending on the complexity of your child’s care, tests and clinic visits may be scheduled over 2 or more days. This may not include test/scan results. The staff at the IWK work hard to schedule and accommodate your child’s needs as best as possible in order to limit the amount of time you spend at the health centre.
- Responsibility
- IWK Hematology / Oncology, Halifax, NS
- Pamphlet Number
- PL-1107
Instructions for Preparing and Giving Chemotherapy by Mouth
https://libcat.nshealth.ca/en/permalink/chpams37987
IWK. Hematology / Oncology, IWK. Nephrology.
Halifax, NS:
IWK Health Centre
, 2022.
- Pamphlet Number
- PL-1108
- Available Online
- View Pamphlet
Depending on the complexity of your child’s care, tests and clinic visits may be scheduled over 2 or more days. This may not include test/scan results. The staff at the IWK work hard to schedule and accommodate your child’s needs as best as possible in order to limit the amount of time you spend at the health centre.
- Available Online
- View Pamphlet
- Corporate Author
- IWK. Hematology / Oncology
- IWK. Nephrology
- Alternate Title
- if your dose, or your child’s dose, is part of a tablet or you or your child cannot swallow a whole tablet
- Place of Publication
- Halifax, NS
- Publisher
- IWK Health Centre
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document : digital, PDF file
- Subjects (MeSH)
- Administration, Oral
- Antineoplastic Agents
- Neoplasms - drug therapy
- Pharmaceutical Preparations
- Subjects (LCSH)
- Cancer--Chemotherapy
- Abstract
- Depending on the complexity of your child’s care, tests and clinic visits may be scheduled over 2 or more days. This may not include test/scan results. The staff at the IWK work hard to schedule and accommodate your child’s needs as best as possible in order to limit the amount of time you spend at the health centre.
- Responsibility
- IWK Hematology / Oncology, Halifax, NS
- Pamphlet Number
- PL-1108
Oral Anticoagulation Therapy : Cases and Clinical Correlation
https://libcat.nshealth.ca/en/permalink/provcat41753
Kathryn Kiser, editor.
--Cham:
Springer
, 2017.
- Available Online
- View e-Book
- Location
- Online
This case-based title reviews anticoagulation management strategies available for a wide variety of clinical scenarios. Designed to aid providers of direct patient care on complex clinical decisions regarding appropriate evidence-based therapy options, patient and agent related variables to consider, as well as expert opinion on the topic. Oral Anticoagulation Therapy: Cases and Clinical Correlation will provide clinicians and trainees with clear clinical cases, commentary, and resources to dev…
- Available Online
- View e-Book
- Other Authors
- Kiser, Kathryn
- Responsibility
- Kathryn Kiser, editor
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- 2017
- Physical Description
- 1 online resource (x, 313 pages) : 6 illus., 2 illus. in color
- ISBN
- 9783319546438
- 9783319546414 (print ed.)
- Subjects (MeSH)
- Administration, Oral
- Anticoagulants - therapeutic use
- Hemorrhage - drug therapy
- Vascular Diseases - drug therapy
- Warfarin - therapeutic use
- Abstract
- This case-based title reviews anticoagulation management strategies available for a wide variety of clinical scenarios. Designed to aid providers of direct patient care on complex clinical decisions regarding appropriate evidence-based therapy options, patient and agent related variables to consider, as well as expert opinion on the topic. Oral Anticoagulation Therapy: Cases and Clinical Correlation will provide clinicians and trainees with clear clinical cases, commentary, and resources to develop their knowledge base, problem-solving skills, and ability to practically apply new knowledge to a variety of clinical situations. Resources provided in cases include valuable figures, tables, and key points designed for the reader to be able to utilize at the point of care.
- Contents
- Part I: Introduction -- 1. Introduction -- Part II: Atrial Fibrillation -- 2. CHA2DS2-VASc and HAS-BLED Risk Stratification Tools -- 3. Male with Priority of Ischemic Stroke Reduction -- 4. Choosing an Anticoagulant in an Elderly Patient -- 5. Patient with Prior History of GI Hemorrhage -- 6. Patients with a History of Intracranial Hemorrhage -- 7. Concerns with Anticoagulant Adherence -- 8. Oral Anticoagulants in Stable Moderate Chronic Kidney Disease -- 9. Oral Anticoagulants in Severe Renal Dysfunction -- 10. Oral Anticoagulants in Patients with Variable Renal Function -- 11. Patient with Concomitant Stable Coronary Artery Disease -- 12. Patient with Concomitant Acute Venous Thromboembolism -- 13. Patient with Concomitant Mitral Valve Stenosis -- 14. Patient with Concomitant Aortic Valve Stenosis -- Part III: Warfarin Management -- 15. Best Practice for Switching Stable Warfarin Patients -- 16. Patient-Centered Strategies for Improving Warfarin Management -- Part IV: Venous Thromboembolism (VTE) -- 17. Provoked Versus Unprovoked Venous Thromboembolism -- 18. Venous Thromboembolism (VTE) Prophylaxis in Hip and Knee Replacement Surgery -- 19. Venous Thromboembolism (VTE) Prophylaxis in the Intensive Care Unit (ICU) -- 20. VTE and Recent Drug Eluting Stent (DES) Placement -- 21. Acute VTE in a Patient with Moderate Chronic Kidney Disease -- 22. Oral Anticoagulation and Duration in Recurrent Venous Thromboembolism (VTE) -- 23. Pulmonary Embolism (PE) with Thrombolytic Therapy -- Part V: Acute Coronary Syndrome (ACS) -- 24. Patient on Oral Anticoagulant Presenting with ACS -- 25. Oral Anticoagulant Therapy Post-Percutaneous Coronary Intervention -- 26. ST-Segment Elevation Myocardial Infarction (Lytic Candidate) on Oral Anticoagulant -- 27. ACS with Bypass Surgery -- Part VI: Drug Interactions -- 28. Anticoagulant Drug-Drug Interactions with CYP 3A4 Inhibitors -- 29. Significance of P-glycoprotein (P-gp) Drug-Drug Interactions -- 30. Considerations with Pharmacodynamic Drug-Drug Interactions -- 31. Management of Direct Oral Anticoagulants with Mixed P-gp/3A4 Drug-Drug Interactions -- 32. Pharmacokinetic Drug-Drug Interactions with Warfarin -- Part VII: Special Populations -- 33. Chronic Pain Management with Anticoagulation -- 34. Anticoagulation Management in Atrial Fibrillation Catheter Ablation -- 35. Anticoagulation Management Considerations for Mechanical Valves -- 36. Management of Antiphospholipid Antibody Syndrome -- 37. Venous Thromboembolism and Pregnancy -- 38. Venous Thromboembolism in Active Malignancy -- 39. Anticoagulation Management in Patients Undergoing Gastric Bypass Procedures -- 40. Patient Presenting with Minor Bleeding -- 41. Patient Presenting with Major, Life-Threatening Bleeding -- 42. Overdose of Dabigatran.
- Format
- e-Book
- Location
- Online
